Insulin-like growth factor-1 rescues synaptic and motor deficits in a mouse model of autism and developmental delay
Open Access
- 27 April 2013
- journal article
- Published by Springer Science and Business Media LLC in Molecular Autism
- Vol. 4 (1), 9
- https://doi.org/10.1186/2040-2392-4-9
Abstract
Background: Haploinsufficiency of SHANK3, due to either hemizygous gene deletion (termed 22q13 deletion syndrome or Phelan-McDermid syndrome) or to gene mutation, accounts for about 0.5% of the cases of autism spectrum disorder (ASD) and/or developmental delay, and there is evidence for a wider role for SHANK3 and glutamate signaling abnormalities in ASD and related conditions. Therapeutic approaches that reverse deficits in SHANK3-haploinsufficiency may therefore be broadly beneficial in ASD and in developmental delay. Findings: We observed that daily intraperitoneal injections of human insulin-like growth factor 1 (IGF-1) over a 2-week period reversed deficits in hippocampal α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) signaling, long-term potentiation (LTP), and motor performance that we had previously reported in Shank3-deficient mice. Positive effects were observed with an IGF-1 peptide derivative as well. Conclusions: We observed significant beneficial effects of IGF-1 in a mouse model of ASD and of developmental delay. Studies in mouse and human neuronal models of Rett syndrome also show benefits with IGF-1, raising the possibility that this compound may have benefits broadly in ASD and related conditions, even with differing molecular etiology. Given the extensive safety data for IGF-1 in children with short stature due to primary IGF-1 deficiency, IGF-1 is an attractive candidate for controlled clinical trials in SHANK3-deficiency and in ASD.Keywords
This publication has 15 references indexed in Scilit:
- Reduced Excitatory Neurotransmission and Mild Autism-Relevant Phenotypes in AdolescentShank3Null Mutant MiceJournal of Neuroscience, 2012
- FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and AutismCell, 2011
- Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3Human Molecular Genetics, 2011
- Excess of De Novo Deleterious Mutations in Genes Associated with Glutamatergic Systems in Nonsyndromic Intellectual DisabilityAmerican Journal of Human Genetics, 2011
- Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communicationMolecular Autism, 2010
- A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem CellsCell, 2010
- Neuronal Activity Drives Localized Blood-Brain-Barrier Transport of Serum Insulin-like Growth Factor-I into the CNSNeuron, 2010
- Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant miceProceedings of the National Academy of Sciences of the United States of America, 2009
- Advances in autism genetics: on the threshold of a new neurobiologyNature Reviews Genetics, 2008
- Contribution of SHANK3 Mutations to Autism Spectrum DisorderAmerican Journal of Human Genetics, 2007